St.Louis Cancer Care, LLP

Bridgeton, Missouri 63044

1 studies enrolling now · 11 studies all time

What they study most

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Advanced Breast Cancer, Advanced Prostate Cancer, Gastroesophageal Junction Adenocarcinoma, Lung Adenocarcinoma Stage IIIB/IV, Lung Cancer, Lung Cancer, Non-squamous, Non-small Cell, Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma, Metastatic Non-Small Cell Lung Cancer, Multiple Myeloma, NSCLC

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION) — Running, not enrolling
• A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) — Running, not enrolling
• Palbociclib in Real World Practice — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Docetaxel for Metastatic Non-Small Cell Lung Cancer (NSCLC) (PRESERVE 4) — Stopped early
• An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T — Stopped early
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer — Stopped early